BUSINESS SNAPSHOT
What does Indo SMC actually do?
Indo SMC is a manufacturer of composite and electrical components servicing India’s power distribution and infrastructure ecosystem. Founded in 2021, it has scaled rapidly from a ₹7 Cr company (FY23) to a ₹139 Cr revenue entity (FY25), targeting ₹300 Cr in FY26.
Three Core Product Lines:
| Segment | Products | Key Customers |
|---|---|---|
| SMC Products | SMC meter boxes, distribution boxes, junction boxes | State DISCOMs, retail channel |
| CT/PT & Metering | Current/Potential Transformers, 11kV metering cubicles, LT CT, bus ducts | MSEDCL, BESCOM, state utilities |
| FRP / Pultrusion | Cable trays, grating, pultruded profiles | Railways, defence, oil & gas (exports) |
Revenue Mix (FY27 Management Targets):
- CT/PT / LTCT / Cubicles: ₹250 Cr (55%)
- SMC Boxes: ₹120–150 Cr (30%)
- FRP / Pultrusion: ₹70–80 Cr (15%)
Three Manufacturing Units:
- Unit 1: Ahmedabad (original)
- Unit 2: Nashik, Maharashtra (MIDC Satpur)
- Unit 3: Rajasthan (RIICO, Kotputli-Behror) — greenfield
WHAT’S CHANGING IN THE BUSINESS?
This was the company’s first-ever earnings call post-listing (Feb 11, 2026). There is no previous concall to compare management tone against. However, several language signals stand out:
Tone Assessment: Confident bordering on Promotional
| Signal | What Was Said | My Read |
|---|---|---|
| Guidance escalation | Internal FY26 target was ₹280–290 Cr; now guiding ₹300 Cr | Modest upgrade — 9M actual of ₹214 Cr makes ₹300 Cr achievable |
| FY27 ambition | “We want to go to almost ₹450 Cr minimum” | Aggressive — implies 50% YoY growth from a base that hasn’t been fully proven |
| Hurdle minimization | “Right now, I can’t see the hurdles because I have already passed them” |  Classic overconfidence language — no acknowledgment of execution risk |
| Working capital improvement | Receivables from 83 days (H1 FY26) → 40 days (Q3 FY26) | Genuine positive signal — most concrete improvement cited |
| State expansion | MSEDCL approval received; AP tenders won; now targeting Maharashtra, Gujarat, Punjab, South | Pipeline is broadening |
| New vectors: Exports | “Sent a container to Oman for trial” | Very early stage — trial shipment only |
| New vectors: Railways/Defence | Mentioned multiple times as growth frontier | No revenue evidence yet — aspirational |
Critical Language Shift to Watch:
The MD-CFO (same person) said the FY27 ₹450 Cr guidance is contingent on “approval pipeline in new states” and “CT/PT adding Maharashtra + Gujarat + Punjab.” This is a conditional guidance dressed as a firm target — investors should parse this carefully.
GUIDANCE ANALYSIS
| Metric | FY25 Actual | FY26 Guidance | FY27 Guidance |
|---|---|---|---|
| Revenue | ₹139 Cr | ₹300 Cr | ₹450 Cr |
| EBITDA Margin | 17% | ~16–17% | 18–19% (target) |
| PAT Margin | 10.8% | ~11% | 11–12% |
| Order Book (exit) | NA | ~₹250 Cr by Mar '26 | NA |
Verdict: Upgrade in tone, but FY27 target is high-conviction only on the CT/PT segment.
- FY26 ₹300 Cr is credible: ₹214 Cr in 9M, Q4 is seasonally strong → ₹86 Cr needed in Q4 vs Q3 run-rate of ₹101 Cr. Achievable.
- FY27 ₹450 Cr: CT/PT guidance of ₹250 Cr (from near-zero to a dominant segment) is the make-or-break assumption. SMC at ₹120–150 Cr needs state-level approvals to convert. FRP at ₹70–80 Cr needs machine delivery + export ramp. High execution dependency.
KEY VALUE-CREATION TRIGGERS
Trigger #1: Government Policy Tailwind (PRIMARY)
India’s RDSS (Revamped Distribution Sector Scheme) and Smart Metering Program are injecting multi-year demand into exactly Indo SMC’s product categories (11kV cubicles, meter boxes, CT/PT). State DISCOMs are under regulatory pressure to reduce AT&C losses → capex cycle in distribution infrastructure. This is a structural demand tailwind, not a cyclical spike.
Why it matters: Unlike telecom or consumer electronics, distribution infrastructure replacement is government-mandated. Demand is less discretionary.
Trigger #2: Operating Leverage at Low Utilization (SECONDARY)
Company explicitly guided 30–40% utilization at IPO → targeting 60–80% by end FY26. Sustainable EBITDA margin guided at 18–19% vs current 16%. Every incremental revenue rupee at current fixed cost base flows through at higher margins.
ROCE was 47.7% in FY25 on thin capital base. Sustaining this as revenue scales will be hard — but if margins expand from 16% → 19%, ROIC trajectory stays healthy.
Trigger #3: Multi-State Approval Moat-in-Progress
The company has received MSEDCL (Maharashtra) vendor approval for 11kV metering cubicles. It is pursuing Gujarat, Punjab, and South India. Vendor approvals from state utilities are sticky — once approved, repeat orders follow for 3-year tender cycles. This is an early-stage process power being constructed.
Trigger #4: Receivables Compression → FCF Generation
Working capital was the biggest overhang: OCF was -₹14 Cr in FY25, debtor days were 124. Q3 FY26 shows dramatic compression to ~40 days. If sustained, this converts PAT into actual cash — currently the stock is a PAT-rich, cash-poor story.
Forensic lens: OCF/PAT ratio in FY25 was deeply negative. Watch Q4 FY26 cash flow statement — it is the first real test of whether the receivables improvement is structural.
WHAT SHOULD AN INVESTOR TRACK?
KPIs for Next 2–4 Quarters:
| KPI | Current | Target | Why It Matters |
|---|---|---|---|
| Q4 FY26 Revenue | ₹101 Cr (Q3) | ₹85+ Cr needed | Validates ₹300 Cr annual guidance |
| OCF/PAT Ratio (FY26 annual) | -0.93x (FY25) | > 0.5x | Earnings quality proof point |
| Debtor Days (FY26 full year) | 124 days (FY25) | < 70 days | Working capital health |
| CT/PT state approvals | 2 states | 4+ states by Q2 FY27 | Determines FY27 ₹250 Cr CT/PT target |
| Order Book (exit Mar '26) | ₹142 Cr (Feb '26) | ~₹250 Cr (guided) | Revenue visibility |
| Export contribution | Trial shipment only | Any confirmed repeat order | FRP/Pultrusion diversification |
Risks That Could Break the Thesis:
- Execution risk on FY27 guidance: ₹450 Cr implies adding ₹150 Cr in CT/PT alone — entirely dependent on state approvals converting to orders in a compressed timeline.
- Working capital relapse: OCF has been negative 3 years in a row. If receivables balloon again in H1 FY27 (monsoon seasonality), financing stress resurfaces.
- Single-person governance risk: MD = CFO = Promoter (Neel Shah). Combined with it being an SME-listed company with 1,497 shareholders — governance oversight is minimal.
- Raw material volatility: Revenues exposed to petroleum (SMC resin), fiber, and metals. No hedging mechanism mentioned. Any input spike compresses margins in a fixed-price tender environment.
- Promoter shareholding dilution concern: IIFL data shows promoters at 48.1% vs Screener’s Jan 2026 figure of 60.09% — this divergence needs verification. If promoter stake has dropped significantly post-IPO, investigate why.
FINANCIAL HEALTH SNAPSHOT
| Metric | FY23 | FY24 | FY25 |
|---|---|---|---|
| Revenue (₹ Cr) | 7 | 28 | 139 |
| EBITDA (₹ Cr) | 1.2 | 5.0 | 23.6 |
| EBITDA Margin | 17% | 18% | 17% |
| PAT (₹ Cr) | 0.5 | 3.3 | 15.1 |
| OCF (₹ Cr) | -3 | -6 | -14 |
| Borrowings (₹ Cr) | 10 | 18 | 36 |
| ROCE | — | 27% | 47.7% |
| ROE | — | — | 74.5% |
| Debtor Days | 70 | 112 | 124 |
| CCC | 356 | 208 | 114 |
PAT/OCF Divergence: Three consecutive years of negative OCF despite positive PAT is a red flag. The company is booking revenue but not collecting cash. Q3 FY26 shows improvement — but annual confirmation is essential.
FINAL INVESTOR INSIGHT
What is the market missing?
The market is pricing this as a generic SME manufacturer. What it may be underweighting is the vendor-approval moat being constructed at state DISCOMs. Once approved at MSEDCL (Maharashtra’s giant utility), repeat tender wins compound over 3-year cycles. The company is at Year 1 of a potential multi-state sticky relationships business.
This is early-stage story. The business model is proven at small scale; the FY27 ₹450 Cr thesis is an execution hypothesis, not an established fact.
One-Line Thesis:
“This stock works if CT/PT metering cubicle state approvals convert into ₹200+ Cr order flow by Q2 FY27, and OCF turns positive in FY26 annual — proving that the PAT is real cash and not just accrual accounting.”
Reverse-DCF Check (Back-of-envelope):
At ₹147 and ~₹335 Cr market cap:
- FY25 PAT ₹15 Cr → P/E ~22x on trailing
- Q3 FY26 annualized PAT: ₹12.1 Cr × 4 = ~₹48 Cr forward → P/E ~7x forward (if ₹300 Cr revenue achieves 12% PAT = ₹36 Cr PAT → forward P/E ~9x)
- At 9x forward P/E on ₹36 Cr PAT, the stock appears cheap IF guidance is deliverable. The market is implying low confidence in guidance conversion — hence the 23% correction from highs.
Disclosure: Invested from lower levels. Not a SEBI registered. This is purely for educational purpose. Consult a SEBI registered expert before making any investment decisions.